TABLE 1 Global Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 2 Global Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 3 North America Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 4 North America Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 5 U.S. Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 6 U.S. Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 7 Canada Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 8 Canada Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 9 Rest of North America Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 10 Rest of North America Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 11 UK and European Union Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 12 UK and European Union Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 13 UK Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 14 UK Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 15 Germany Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 16 Germany Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 17 Spain Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 18 Spain Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 19 Italy Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 20 Italy Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 21 France Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 22 France Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 23 Rest of Europe Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 24 Rest of Europe Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 25 Asia Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 26 Asia Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 27 China Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 28 China Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 29 Japan Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 30 Japan Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 31 India Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 32 India Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 33 Australia Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 34 Australia Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 35 South Korea Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 36 South Korea Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 37 Latin America Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 38 Latin America Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 39 Brazil Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 40 Brazil Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 41 Mexico Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 42 Mexico Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 43 Rest of Latin America Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 44 Rest of Latin America Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 45 Middle East and Africa Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 46 Middle East and Africa Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 47 GCC Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 48 GCC Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 49 Africa Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 50 Africa Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)
TABLE 51 Rest of Middle East and Africa Multiple Sclerosis Drugs Market By Molecule, 2022-2032, USD (Million)
TABLE 52 Rest of Middle East and Africa Multiple Sclerosis Drugs Market By Route of Administration, 2022-2032, USD (Million)